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We describe the first case of bloodstream infection caused by Rhodococcus erythropolis. The identification was
performed using 16S rRNA sequencing. This case illustrates that non-equi Rhodococcus infections may be
underdiagnosed due to difficulties in identification in the routine clinical microbiology laboratory.
CASE REPORT
A 79-year-old man with esophageal cancer was admitted to
the hospital for radiotherapy followed by chemotherapy. Par-
enteral nutrition was administered by a peripheral venous
catheter. Three weeks after hospital admission, the patient
developed a fever (38.4°C). History and physical examination
did not reveal an obvious source of infection. The leukocyte
count was 1,700/mm3 with 1,300 neutrophils/mm3. The C-re-
active protein was elevated at 4.34 mg/dl. Chest radiographic
findings were normal. Three sets of blood cultures were col-
lected, and antibiotic treatment with intravenous cefopera-
zone-sulbactam (2 g twice daily) was initiated empirically. The
blood cultures were incubated at 37°C in the Bact/Alert system
(bioMe´rieux, Marcy l’Etoile, France) and became positive for
a gram-positive rod on the fourth day of incubation. All three
sets of blood cultures were positive. The fever gradually dimin-
ished under treatment with cefoperazone-sulbactam. Local
redness at the peripheral venous catheter site was noted, and
the catheter was removed.
Fever recurred, despite ongoing treatment with cefopera-
zone-sulbactam. Blood cultures collected 10 days after the
initial sets were collected again grew a gram-positive rod,
which appeared phenotypically identical to the earlier isolates.
There was no evidence of endocarditis on transthoracic echo-
cardiography. Computed tomography scans and ultrasonogra-
phy of the proximal vein within which the catheter was inserted
showed no evidence of thrombophlebitis. Treatment was then
changed to a second-generation cephalosporin, cefotiam (1 g
three times daily), and the peripheral venous catheter was
again removed. No further fever was observed, and the patient
was discharged from the hospital 1 month after the final set of
blood cultures was collected.
All four isolates grew in the aerobic bottle of the Bact/Alert
system. After 72 h of aerobic incubation at 37°C, smooth white
colonies grew on 5% sheep blood agar. The API Coryne sys-
tem (bioMe´rieux, Marcy l’Etoile, France) was used for the
initial identification according to the manufacturer’s instruc-
tions. The results were positive for pyrazinamidase, alkaline
phosphatase, -glucosidase, esculin, urease, and catalase and
negative for nitrate, pyrrolidonyl arylamidase, -glucuroni-
dase, -galactosidase, N-acetyl--glucosaminidase, gelatinase,
and carbohydrate fermentation tests. The isolates gave a pro-
file number of 2151004 and were identified as Rhodococcus
spp. (98.8% identification; T index, 0.89).
To strengthen this biochemical identification, molecular
identification was attempted by PCR amplification and se-
quencing analyses. A 1,450-bp sequence of the 16S rRNA gene
was amplified with universal primers 8UA (5-AGAGTTTGA
TCMTGGCTCAG-3) and 1485B (5-ACGGGCGGTGTGT
RC-3), as described previously (14). Sequencing analysis was
performed using a GenBank BLAST search. Sequence editing
and phylogenetic analyses were performed with CLUSTAL W
(neighbor-joining method) with Treeview. The sequence of the
16S rRNA gene (accession number AB499800) was 99.4%
identical (1,441 bp over the entire 1,449-bp fragment) with that
of Rhodococcus erythropolis strain DSM 43188T (X80618). The
16S rRNA gene sequence of the isolate from our case differed
by 55 bp (96.2% identical), 56 bp (96.1% identical), and 42 bp
(97.0% identical) from that of Rhodococcus equi DSM 40307T
(X80614), Rhodococcus rhodochrous DSM 43241T (X79288),
and Rhodococcus fascians DSM 20669T (X79186), respectively.
The MICs of the following antimicrobial agents were deter-
mined by the broth microdilution method according to the
Clinical and Laboratory Standards Institute guidelines for aer-
obes (3): penicillin, 2 g/ml; cefotiam, 1 g/ml; cefopera-
zone-sulbactam, 4 g/ml; vancomycin, 0.5 g/ml; clindamycin,
1 g/ml; tetracycline, 2 g/ml; gentamicin, 1 g/ml; and
rifampin (rifampicin), 1 g/ml.
Rhodococcus belongs to the order Actinomycetales and the
family Nocardiaceae (1, 12). Rhodococcus are obligate aerobic,
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gram-positive bacilli and partially acid-fast like Nocardia be-
cause of their mycolic acid-containing cell wall. They have been
isolated from a large variety of sources, including soils, rocks,
ground water, seawater, plants, animals, and the guts of insects
(1, 12). Rhodococci have broad catabolic diversity and unique
enzymatic capabilities. Their ability to transform or degrade a
wide range of chemicals raises the potential usefulness of
rhodococci in environmental or industrial biotechnology (1, 5).
Although Rhodococcus species are generally considered to
have low pathogenicity, they cause diseases in animals, plants,
and humans. Since the first clinical case caused by R. equi,
formerly Corynebacterium equi, was reported in 1967, the sig-
nificance of Rhodococcus in humans, especially among immu-
nocompromised hosts, is increasing. This is both in terms of
the actual occurrence of infection and the extent to which it is
recognized (1, 18). However, most Rhodococcus human infec-
tions have been caused by R. equi, and only a few cases were
reported for other species, for example, R. rhodochrous and R.
fascians (formerly R. luteus) (6, 9, 17).
R. erythropolis was originally called Mycobacterium erythropo-
lis by Gray and Thornton in 1928, during an investigation of
soil bacteria (11). “Erythropolis” is literally from the Greek
meaning “red city,” in reference to the orange and red colonies
sometimes observed (7). After a period of being known as
Nocardia erythropolis, the organism is now known as R. eryth-
ropolis. R. erythropolis is a bacterium that attracts some atten-
tion in the biotechnology field (5), because it is solvent toler-
ant. It contains a large set of enzymes, allowing it to carry out
oxidations, dehydrogenations, epoxidations, hydrolysis, hy-
droxylations, dehalogenations, and desulfurizations. Thus, it
may have considerable potential as a biocatalyst, especially in
nonconventional systems. R. erythropolis may occur naturally in
contaminated environments, thus allowing it to be used in the
bioremediation of polluted sites, for example (5).
R. erythropolis is typically found in soil. It has been detected
on the surface of the healthy human eye (in conjunctival sam-
ples) (10). There are no other reports of its presence at other
sites (skin, fecal flora, etc.) of the normal human body. The
typical colony of R. erythropolis has been described to be rough
and orange to red colored on glucose yeast extract agar and
Sauton’s agar (7). However, these colonial features are not
always observed. In R. erythropolis, the morphogenetic cycle is
elementary branching-rod-coccus (13). R. erythropolis produces
acid from glucose, glycerol, sorbitol, sucrose, and trehalose and
not from adonitol, arabinose, cellobiose, galactose, glycogen,
inulin, melezitose, rhamnose, and xylose (7). R. erythropolis
differs from R. equi in its ability to grow on the following sole
carbon sources: maltose, mannitol, glycerol, sorbitol, sodium
adipate, sodium citrate, sodium gluconate, butan-2,3-diol, se-
bacic acid, citraconic acid, D-mandelic acid, and L-asparagine
(7, 13). It is noteworthy that the colonial appearance of the
genus Rhodococcus is quite variable and that phenotypic tests
available in the clinical laboratory may be insufficient to dif-
ferentiate the organism from other species. Therefore, it is
impossible to obtain reliable species-level identification with-
out resorting to molecular methods (4, 8).
To the best of our knowledge, four cases of human infection
with R. erythropolis have been previously described, although
not all have used molecular confirmation of species identifica-
tion. Brown and Hendler reported peritonitis caused by R.
erythropolis during continuous ambulatory peritoneal dialysis
(2). Vernazza et al. reported a disseminated skin infection in a
human immunodeficiency virus-infected patient, which was
successfully treated with long-term amoxicillin (amoxicilline)-
clavulanic acid therapy (16). von Below et al. identified R.
erythropolis in chronic endophthalmitis after lens implantation
(17). In this case, they needed to remove the implant and
perform anterior vitrectomy plus the coadministration of ce-
fotiam and amikacin. Finally, Osoagbaka from Nigeria de-
scribed the isolation of R. erythropolis from sputum in a patient
with pneumonia (15).
Thus, our case represents the first case of bloodstream in-
fection with this organism. The source of infection is not en-
tirely clear. Treatment with the second-generation cephalospo-
rin cefotiam was successful. (This antibiotic is only available in
Japan and some countries in Europe.) It is quite possible that
the non-equi Rhodococcus infections are underdiagnosed due
to difficulties in species identification and the delay in the
growth of the organism. There is also a risk of the dismissal of
these gram-positive bacilli as contaminating “diphtheroids.” In
our case, identification was confirmed by use of 16S rRNA
sequencing, a useful molecular technique for speciation of the
genus Rhodococcus. As the pool of immunosuppressed pa-
tients increases in the future, future cases of infection with
non-equi Rhodococcus species such as R. erythropolis are ex-
pected.
We thank Amanda Jones and Michael Goodfellow of the University
of Newcastle, United Kingdom, for their review of the sequencing and
identification of the organism.
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